Biogen Inc. Profile Avatar - Palmy Investing

Biogen Inc.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spina…

Drug Manufacturers - General
US, Cambridge [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Biogen Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of BIIB's Analysis
CIK: 875045 CUSIP: 09062X103 ISIN: US09062X1037 LEI: - UEI: -
Secondary Listings